SuperGen’s PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models13 June 2008/in 2008, NewsSuperGen’s PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg 0 0 webadmin https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg webadmin2008-06-13 12:58:582016-11-28 12:59:20SuperGen’s PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models
